帕金森病市場的腦深部刺激療法：副產品（雙通道、單通道）、最終用戶（門診手術中心、醫院、神經科診所）-俄羅斯-烏克蘭衝突和高通脹-2023-2030年全球市場預測

預計帕金森病腦深部刺激療法的全球市場將在 2023 年達到 10.751 億美元，複合年增長率為 15.33%，預計到 2030 年將大幅增長，達到 29.3075 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球帕金森病市場深部腦刺激療法至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面信息。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細信息。

4. 市場趨勢：全面了解 COVID-19、俄羅斯-烏克蘭衝突和高通脹的累積影響。

5.競爭評估和信息：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.帕金森病腦深部刺激治療的全球市場規模和預測是多少？

2. 在預測期內，COVID-19 影響全球帕金森病深部腦刺激療法市場的抑制因素和影響是什麼？

3.在預測期內，全球帕金森病腦深部刺激療法市場需要投資哪些產品/細分市場/應用/領域？

4.帕金森病腦深部刺激治療全球市場的競爭策略是什麼？

5.帕金森病腦深部刺激治療全球市場的技術趨勢和監管框架是什麼？

6. 全球帕金森病腦深部刺激治療市場主要廠商的市場份額是多少？

7. 哪些形式和戰略舉措被認為適合進入帕金森病腦深部刺激療法的全球市場？

目錄

第一章前言

第二章研究方法

第 3 章執行摘要

第四章市場概述

第 5 章市場洞察

• 市場動態
  • 促進因素
    • 神經系統疾病的發生率增加
    • 人口迅速老齡化正在增加神經系統疾病的風險和患病率
    • 微創手術日益普及
  • 抑制因素
    • 複雜的監管框架
  • 機會
    • 設備技術進步
    • 神經學研究和開發的激增
  • 作業
    • 深部腦刺激手術的並發症
• 市場趨勢
• 新冠肺炎 (COVID-19) 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通脹的累積影響
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 監管框架
• 客戶定制

第6 章帕金森病市場中的深部腦刺激療法：副產品（雙通道、單通道）、最終用戶（門診手術中心、醫院、神經科診所）- 俄羅斯-烏克蘭衝突和高通貨膨脹- 全球市場：By產品

• 雙通道
• 單通道

第7 章帕金森病市場的深部腦刺激療法：副產品（雙通道、單通道）、最終用戶（門診手術中心、醫院、神經科診所）- 俄羅斯-烏克蘭衝突和高通貨膨脹- 全球市場：最終用戶

• 門診手術中心
• 醫院
• 神經科診所
• 研究中心

第 8 章：美洲帕金森病的腦深部刺激治療市場：副產品（雙通道、單通道）、最終用戶（門診手術中心、醫院、神經科診所） - 俄羅斯-烏克蘭衝突和高通貨膨脹 -世界市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太地區帕金森病腦深部電刺激治療市場：副產品（雙通道、單通道）、最終用戶（門診手術中心、醫院、神經內科診所） - 俄羅斯-烏克蘭衝突和高通脹- 世界市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第 10 章歐洲、中東和非洲帕金森病腦深部刺激治療市場：副產品（雙通道、單通道）、最終用戶（門診手術中心、醫院、神經科診所）- 俄羅斯-烏克蘭衝突和高風險通貨膨脹- 世界市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 意大利
• 荷蘭
• 尼日利亞
• 挪威
• 波蘭
• 卡塔爾
• 俄羅斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合酋長國
• 英國

第11章競爭態勢

• FPNV定位矩陣
• 市場份額分析：按主要公司劃分
• 競爭情景分析：主要公司

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和價格

The Global Deep Brain Stimulation in Parkinson's Disease Market is forecasted to grow significantly, with a projected USD 1,075.10 million in 2023 at a CAGR of 15.33% and expected to reach a staggering USD 2,930.75 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Deep Brain Stimulation in Parkinson's Disease Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Deep Brain Stimulation in Parkinson's Disease Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Dual Channel and Single Channel. The Dual Channel is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Neurology Clinics, and Research Centers. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Deep Brain Stimulation in Parkinson's Disease Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Deep Brain Stimulation in Parkinson's Disease Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Deep Brain Stimulation in Parkinson's Disease Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Deep Brain Stimulation in Parkinson's Disease Market?

4. What is the competitive strategic window for opportunities in the Global Deep Brain Stimulation in Parkinson's Disease Market?

5. What are the technology trends and regulatory frameworks in the Global Deep Brain Stimulation in Parkinson's Disease Market?

6. What is the market share of the leading vendors in the Global Deep Brain Stimulation in Parkinson's Disease Market?

7. What modes and strategic moves are considered suitable for entering the Global Deep Brain Stimulation in Parkinson's Disease Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Deep Brain Stimulation in Parkinson's Disease Market, by Product, 2022 vs 2030
• 4.3. Deep Brain Stimulation in Parkinson's Disease Market, by End-User, 2022 vs 2030
• 4.4. Deep Brain Stimulation in Parkinson's Disease Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of neurological diseases
    • 5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
    • 5.1.1.3. Rising popularity of minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Complex regulatory framework
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing technological advancement in devices
    • 5.1.3.2. Surge in neurological R&D
  • 5.1.4. Challenges
    • 5.1.4.1. Complications of deep brain stimulation surgery
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Deep Brain Stimulation in Parkinson's Disease Market, by Product

• 6.1. Introduction
• 6.2. Dual Channel
• 6.3. Single Channel

7. Deep Brain Stimulation in Parkinson's Disease Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals
• 7.4. Neurology Clinics
• 7.5. Research Centers

8. Americas Deep Brain Stimulation in Parkinson's Disease Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

1. Abbott Laboratories

2. Aleva Neurotherapeutics SA

3. Beijing Pins Medical Co.,Ltd.

4. Boston Scientific Corporation

5. Functional Neuromodulation Ltd.

6. General Electric Co.

7. Medtronic PLC

8. MicroTransponder Inc.

9. Neuronetics Inc.

10. NeuroPace Inc.

11. NeuroSigma, Inc.

12. Nexstim Oy

13. Renishaw PLC

14. Siemens AG

15. St. Jude Medical, Inc.

16. Synapse Biomedical Inc.

LIST OF FIGURES

• FIGURE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET RESEARCH PROCESS
• FIGURE 2. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2022 VS 2030
• FIGURE 3. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET DYNAMICS
• FIGURE 8. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 8. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. POLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 99. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 100. DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET LICENSE & PRICING